Renescience A/S: Financial statements 2014
CVR: 31846803
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
Renescience A/S (CVR 31846803) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -26,446,000 and a net result of DKK -19,400,000 compared with DKK -19,925,000 the year before. Equity in the 2014 report amounted to DKK 33,280,000. The solvency ratio was 87%.
- Gross Profit
- DKK -26,446,000
- Profit/Loss
- DKK -19,400,000
- Equity
- DKK 33,280,000
- Total Assets
- DKK 38,231,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -26.4 mio. | -19.4 mio. | 33.3 mio. | - |
| 2013 | - | -25.6 mio. | -19.9 mio. | 27.7 mio. | - |
| 2012 | - | -21 mio. | -16.6 mio. | 17.6 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
Renescience A/S has published its annual report for 2013. Gross profit came to DKK -25,570,000, and the net result was DKK -19,925,000.
As of May 28, 2014, Jacob Moesgård has joined the board of directors of Renescience A/S.
As of May 28, 2014, Mikael Brandt has left the board of directors of Renescience A/S.
About Renescience A/S
Renescience A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named RENESCIENCE A/S and DE S&D NR. 1 2008 A/S. The management consists of Thomas Søndergaard Lyse. The board consists of Ole Thomsen (chair), Jens Grymer and Thomas Søndergaard Lyse. The company is owned by Ørsted New Bio Solutions Holding A/S. According to the 2025 annual report, the company had an average of 1,000 employees. In 2025, the company reported revenue of DKK 21,000 and a net result of DKK -503,937,000 compared with DKK -23,904,000 the year before. Equity in the 2025 report amounted to DKK 73,470,000.